Clinical Evaluation of Initial Experiences With the Qualitative Dual Detection of Core Antigen and Antibodies Immunoassay for Hepatitis C Virus Screening Test
The Elecsys HCV Duo immunoassay effectively simplified HCV diagnosis and facilitated early detection and treatment initiation. Although false-negative HCV Ag results occurred, the assay ensured linkage to care for patients with both HCV Ag and anti-HCV positivity. These advancements may contribute to enhanced HCV care and support national elimination efforts.
Authors
- Yuji Kita
- Shunsuke Sato (ORCID: https://orcid.org/0000-0002-7480-7283)
- Yuji Shimada (ORCID: https://orcid.org/0000-0003-1648-7565)
- Takuya Genda (ORCID: https://orcid.org/0000-0003-0006-8948)
- N Ashikawa
- Masahiro Yamaguchi (ORCID: https://orcid.org/0000-0001-5094-506X)
- Hiroki Nago
- Rihwa Om
- Sho Sato (ORCID: https://orcid.org/0000-0001-5628-7141)
- Yuji Ikeda (ORCID: https://orcid.org/0000-0002-0036-2365)
- Yoko Kato (ORCID: https://orcid.org/0000-0002-4328-1987)
- Ayato Murata
- Yumiko Kodama
- Yuichiro Terai
- Kei Kondo
Institutions
- Juntendo University Shizuoka Hospital (JP)
Publication Details
- Journal
- Hepatology Research
- Published
- 2025-09-10
- DOI
- https://doi.org/10.1111/hepr.70037
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00